U.S. Markets closed

Vanda Pharmaceuticals (VNDA) Catches Eye: Stock Jumps 8.7%

Zacks Equity Research
1 / 2

Should You Buy Sempra Energy (SRE) Ahead of Earnings?

Sempra Energy (SRE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Vanda Pharmaceuticals Inc. VNDA was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $18.25 to $20.65 in the past one-month time frame.

The upside was driven by the news that the company would be added to the S&P 600 index.

The company has seen one negative estimate revision in the past month, while its Zacks Consensus Estimate for the current quarter has also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Vanda Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Vanda Pharmaceuticals Inc. Price

Vanda Pharmaceuticals Inc. Price | Vanda Pharmaceuticals Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider a better-ranked stock like Cambrex Corporation CBM, which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is VNDA going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cambrex Corporation (CBM) : Free Stock Analysis Report
 
Vanda Pharmaceuticals Inc. (VNDA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.